Efficient, Flexible Facilities for the 21st Century

  title={Efficient, Flexible Facilities for the 21st Century},
  author={Howard L. Levine and Jan E. Lilja and Rick Stock and Hans G. K. Hummel and Susan D Jones},
A number of recent improvements in the engineering of high-titer expression vectors, in biopharmaceutical process development, and in facility construction have converged to present new opportunities for cost-effective, f lexible, biomanufacturing facility construction. The evolution of requirements for biopharmaceutical facilities is driven by globalization of the biopharmaceutical industry, patent expirations of several blockbuster biopharmaceutical products, and the increasing shift in new… CONTINUE READING


Publications referenced by this paper.
Showing 1-10 of 42 references

Biosimilars : The Challenge and Opportunities for Industry

  • J Schletter
  • Informa Life Sciences ’ Tenth Annual…
  • 2012

Biosimilars: The Challenge and Opportunities for Industry. Informa Life Sciences

  • J. Schletter
  • Tenth Annual BioProduction Conference,
  • 2012

A Brief Review on Evolving Cell Culture Based Manufacturing Processes and Technology Drivers Over the Past 25 Years

  • W. Noe
  • Cambridge Healthtech Institute’s Peptalk…
  • 2011

A Step Toward Standardizing Films for Single-Use Bioprocessing Vessels

  • J Craig, R. Bhella
  • BioProcess Int
  • 2011

An Environmental Life Cycle Assessment Comparing Single-Use and Conventional Process Technology

  • M Pietrzykowski
  • BioPharm Int
  • 2011

Bravely Deploying Single Use Technologies at Commercial Scale. IBC Life Sciences

  • B. Ciambrone
  • Eighth International Single-Use Applications for…
  • 2011

Deploying and Using Containerized/Modular Data Center Facilities (white paper #42)

  • R Bednar
  • The Green Grid Association: Beaverton OR,
  • 2011

Improving Process Monitoring Capabilities in SUB Bioprocess Development

  • W Whitford
  • IBC Life Sciences ’ Antibody Development and…
  • 2011

Similar Papers

Loading similar papers…